No |
Name |
Type |
Devt Phase /Application |
Slide Deck |
1 |
Small Molecule |
Preclinical Testing |
||
2 |
Small Molecule |
Preclinical Testing |
||
3 |
Small Molecule |
Preclinical Testing |
||
4 |
ADC |
Preclinical Testing |
||
5 |
ADC |
Preclinical Testing |
||
6 |
Biologics |
Preclinical Testing |
||
7 |
Anti-IL-20 mAb for Rheumatoid Arthritis |
Biologics |
Preclinical Testing |
|
8 |
Biologics |
Lead Discovery /Optimization |
||
9 |
PD-L1-blocking scFv Regional Delivery by Anti-Globo H CAR-T Cells for Solid Tumor Treatment |
Biologics |
Lead Discovery /Optimization |
|
10 |
PD-L1/TIM-3/CSF-1R antibody in preclinical studies for Cancer Immunotherapy |
Biologics |
Lead Discovery /Optimization |
|
11 |
Platform |
Cell Therapy |
||
12 |
Bispecific Antibody Technology for Therapeutics - Asymmetric IgG-like |
Platform |
Antibody, Protein, Peptide |
|
13 |
Platform |
Antibody, Protein, Peptide |
||
14 |
Platform |
Antibody, Protein, Peptide |
||
15 |
Platform |
Antibody, Protein, Peptide |